“…Gadofluorine P is a daughter product of gadofluorine M (Bayer Schering Pharma, Berlin, Germany; molecular weight, 1528 Da) with improved tolerability. 20 Gadofluorine agents interact strongly with hydrophobic proteins in blood and extracellular tissue, leading to a breakdown of the micelles. In addition, gadofluorine P binds reversibly to plasma proteins and forms semistable, macromolecular gadofluorine-protein complexes after intravenous injection.…”